Two-year clinical follow-up after pulmonary vein isolation using high-intensity focused ultrasound (HIFU) and an esophageal temperature-guided safety algorithm

Heart Rhythm. 2012 Mar;9(3):407-13. doi: 10.1016/j.hrthm.2011.09.072. Epub 2011 Oct 4.

Abstract

Background and objective: High-intensity frequency ultrasound (HIFU) can achieve pulmonary vein isolation (PVI), but severe complications have happened. An esophageal temperature (ET)-guided safety algorithm was implemented. We investigated medium-term outcome.

Methods: After left atrial access, HIFU was applied until complete PVI. The safety algorithm was as follows: ≤3 complete ablations per pulmonary vein, early abortion when ET ≥40.0°C, use of Power Modulation at ET >39.0°C or when after 20 to 30 seconds no change in PV electrograms: to reduce the ablation temperature in the surrounding tissue, acoustic power is switched on and off with a frequency of 1 Hz; in all first ablations, use of Power Modulation after 50% of programmed time. Touch-up radiofrequency ablation when PVI failed. Follow-up included interviews and Holter electrocardiograms. Recurrence was defined as atrial fibrillation (AF) >30 seconds without a blanking period.

Results: A total of 28 symptomatic patients (18 males, age 63 years), with paroxysmal AF (n = 19) and persistent AF (n = 9) were included. After a median follow-up of 738 days, 22 of the 28 patients (79%) were free of AF without antiarrhythmic drugs. After 1 repeat procedure with radiofrequency ablation, 5 patients remained free of AF. The complications were as follows: 1 lethal atrial-to-esophageal fistula at day 31, 1 pericardial effusion at day 48, 1 unexplained death at day 49, and 2 persistent phrenic nerve palsies with full recovery within 12 months.

Conclusions: Two-year follow-up after PVI using HIFU and an ET-guided safety algorithm shows success rates similar to those of radiofrequency-based procedures but with higher complication rates. Importantly, the ET-guided safety algorithm failed to prevent severe complications. HIFU does not meet safety standards required for the treatment of AF, and this led to a halt of its clinical use.

MeSH terms

  • Algorithms
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / methods
  • Electrocardiography, Ambulatory
  • Equipment Safety
  • Esophagus / physiopathology
  • Female
  • Follow-Up Studies
  • Heart Conduction System / physiopathology
  • Heart Conduction System / surgery
  • Hot Temperature / adverse effects*
  • Humans
  • Intraoperative Complications* / etiology
  • Intraoperative Complications* / prevention & control
  • Male
  • Middle Aged
  • Monitoring, Physiologic / methods
  • Pulmonary Veins / surgery*
  • Pulsed Radiofrequency Treatment / methods*
  • Secondary Prevention
  • Treatment Outcome
  • Ultrasonography, Interventional / adverse effects
  • Ultrasonography, Interventional / methods

Substances

  • Anti-Arrhythmia Agents